中
中文
繁体
English
About Us
About Us
Awards
Development Milestones
Our Culture
Social responsibility
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
News
Company News
Featured Report
With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030”
With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030”
Products
CNS Diseases
Oncology
Anti-infectives
Diabetes
Gastrointestinal
Cardiovascular
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Hansoh is committed to innovation and research in the six therapeutic areas, including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. Constantly
Investor Relations
Information Disclosure
Corporate Governance
Contact for Investors
Corporate Social Responsibility Report
As one of the few research-driven pharmaceutical companies ranking top in some treatment fields with the largest scale, the fastest growth and huge clinical demand...
As one of the few research-driven pharmaceutical companies ranking top in some treatment fields with the largest scale, the fastest growth and huge clinical demand...
As one of the few research-driven pharmaceutical companies ranking top in some treatment fields with the largest scale, the fastest growth and huge clinical demand...
As one of the few research-driven pharmaceutical companies ranking top in some treatment fields with the largest scale, the fastest growth and huge clinical demand...
R&D
R&D System
R&D Platform
R&D Achievements
National-level R&D Designations
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Services
Marketing Network
International Market
Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
搜索
CNS Diseases
CNS Diseases
Oncology
Oncology
Anti-infectives
Anti-infectives
Diabetes
Diabetes
Gastrointestinal
Gastrointestinal
Cardiovascular
Cardiovascular
News
Technology and Innovations
R&D System
We have two R&D centers located in Lianyungang and Zhangjiang, Shanghai. Our dedicated professional R&D team consists of approximately 1,200 full-time employees, led by high-caliber and highly-skilled talent pool. More than 350 of them hold a master’s degree or above.
R&D Platform
Our in-house R&D activities span the entire R&D process, including chemical compound design and screening, pharmacological and toxicological studies, CMC, as well as clinical development.
R&D Achievements
We have undertaken more than 40 national programs，including the National Science and Technology Major Project. We had a pipeline of nearly 100 drug candidates, six of which are Category 1.1 innovative drugs with new molecular entities.
Key National Laboratories
Established in 2014, mainly engaged in scientific researches including R&D of key technologies, new drug R&D, talent training and team development.
About Hansoh
